APA (7th ed.) Citation

Long, E., Stanway, J., White, M., Goudie, N., Phillipson, J., Morton, M., . . . Isaacs, J. (2025). Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: Protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis. Trials, 26(1), 1. https://doi.org/10.1186/s13063-025-08972-x

Chicago Style (17th ed.) Citation

Long, Ema-Louise, et al. "Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) Study: Protocol for a Single-centre, Experimental Medicine Study Investigating the Route of Delivery and Potential Efficacy of Autologous Tolerogenic Dendritic Cell (TolDC) Therapy for Rheumatoid Arthritis." Trials 26, no. 1 (2025): 1. https://doi.org/10.1186/s13063-025-08972-x.

MLA (9th ed.) Citation

Long, Ema-Louise, et al. "Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) Study: Protocol for a Single-centre, Experimental Medicine Study Investigating the Route of Delivery and Potential Efficacy of Autologous Tolerogenic Dendritic Cell (TolDC) Therapy for Rheumatoid Arthritis." Trials, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s13063-025-08972-x.